리브존제약그룹(Livzon Pharmaceutical Group Inc.): 손익 계산서 (TTM)

리브존제약그룹(Livzon Pharmaceutical Group Inc.)
HK ˙ SEHK ˙ CNE100001QV5
HK$26.32 ↓ -0.34 (-1.28%)
2026-06-05
주가
손익 계산서 (TTM)

리브존제약그룹(Livzon Pharmaceutical Group Inc.) 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 11,661 11,964 12,064 12,193 12,131 12,183 12,630 12,564 13,017 12,796 12,430 12,260 12,022 11,857 11,812 11,750 11,802 11,847 12,020 11,711
변화 (%) 2.60 0.83 1.07 -0.51 0.43 3.67 -0.52 3.61 -1.70 -2.86 -1.37 -1.94 -1.38 -0.38 -0.53 0.44 0.38 1.47 -2.58
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 4,151 4,264 4,309 4,364 4,375 4,378 4,577 4,659 4,790 4,787 4,772 4,658 4,506 4,395 4,249 4,218 4,224 4,208 4,135 4,000
변화 (%) 2.74 1.06 1.27 0.24 0.08 4.53 1.81 2.80 -0.07 -0.30 -2.40 -3.25 -2.47 -3.32 -0.73 0.15 -0.38 -1.74 -3.26
수익의 % 35.59 35.64 35.72 35.79 36.06 35.94 36.24 37.09 36.80 37.41 38.39 37.99 37.48 37.06 35.97 35.89 35.79 35.52 34.40 34.16
총 영업 이익 7,510 7,700 7,754 7,829 7,756 7,804 8,053 7,904 8,227 8,009 7,658 7,602 7,516 7,462 7,564 7,532 7,578 7,639 7,885 7,710
변화 (%) 2.53 0.71 0.96 -0.93 0.62 3.18 -1.85 4.08 -2.64 -4.39 -0.72 -1.13 -0.72 1.36 -0.41 0.60 0.80 3.23 -2.22
수익의 % 64.41 64.36 64.28 64.21 63.94 64.06 63.76 62.91 63.20 62.59 61.61 62.01 62.52 62.94 64.03 64.11 64.21 64.48 65.60 65.84
판매관리비 4,368 4,550 4,556 4,552 4,473 4,438 4,550 4,373 4,590 4,404 4,268 4,215 4,042 3,877 3,873 3,759 3,842 4,006 4,181 4,088
변화 (%) 4.16 0.13 -0.08 -1.74 -0.77 2.52 -3.90 4.96 -4.05 -3.08 -1.25 -4.11 -4.06 -0.10 -2.94 2.19 4.27 4.37 -2.22
수익의 % 37.46 38.03 37.76 37.33 36.87 36.43 36.03 34.81 35.26 34.42 34.34 34.38 33.62 32.70 32.79 31.99 32.55 33.81 34.78 34.91
연구개발 1,085 1,086 1,146 1,203 1,193 1,338 1,427 1,450 1,483 1,434 1,335 1,261 1,215 1,083 1,033 1,011 975 982 938 891
변화 (%) 0.15 5.48 4.96 -0.76 12.13 6.60 1.62 2.29 -3.32 -6.89 -5.49 -3.72 -10.80 -4.62 -2.14 -3.61 0.76 -4.50 -4.97
수익의 % 9.30 9.08 9.50 9.86 9.84 10.98 11.30 11.54 11.39 11.20 10.74 10.29 10.10 9.14 8.75 8.61 8.26 8.29 7.80 7.61
운영 비용 9,739 10,071 10,147 10,273 10,092 10,322 10,697 10,638 11,099 10,770 10,509 10,273 9,875 9,505 9,276 9,097 9,133 9,285 9,394 9,146
변화 (%) 3.42 0.75 1.24 -1.75 2.28 3.64 -0.55 4.33 -2.96 -2.43 -2.24 -3.88 -3.75 -2.41 -1.93 0.39 1.67 1.17 -2.64
수익의 % 83.52 84.18 84.11 84.25 83.19 84.72 84.70 84.68 85.27 84.17 84.54 83.80 82.14 80.16 78.53 77.42 77.38 78.38 78.15 78.10
영업 이익 1,922 1,893 1,917 1,921 2,039 1,861 1,932 1,925 1,918 2,026 1,921 1,986 2,148 2,352 2,536 2,653 2,669 2,562 2,627 2,565
변화 (%) -1.52 1.29 0.17 6.15 -8.72 3.83 -0.37 -0.37 5.64 -5.17 3.39 8.12 9.52 7.83 4.59 0.62 -4.03 2.54 -2.35
수익의 % 16.48 15.82 15.89 15.75 16.81 15.28 15.30 15.32 14.73 15.83 15.46 16.20 17.86 19.84 21.47 22.58 22.62 21.62 21.85 21.90
이자 비용 -54 -81 -84 -93 -95 -84 -98 -97 -99 -101 -102 -102 -100 -96 -89 -81 -72 -64 -57 -52
변화 (%) 49.47 3.39 11.17 2.14 -11.77 15.93 -0.83 2.14 2.37 0.92 0.16 -2.54 -3.99 -7.38 -8.92 -10.46 -11.37 -10.68 -9.12
수익의 % -0.47 -0.68 -0.70 -0.77 -0.79 -0.69 -0.77 -0.77 -0.76 -0.79 -0.82 -0.83 -0.83 -0.81 -0.75 -0.69 -0.61 -0.54 -0.48 -0.44
당기순이익 1,773 1,746 1,776 1,809 1,731 1,830 1,909 1,938 2,026 2,004 1,954 1,980 1,990 2,025 2,061 2,090 2,171 2,142 2,023 1,963
변화 (%) -1.50 1.69 1.89 -4.34 5.72 4.35 1.50 4.56 -1.10 -2.52 1.33 0.53 1.75 1.79 1.40 3.89 -1.32 -5.56 -2.96
수익의 % 15.20 14.59 14.72 14.84 14.27 15.02 15.12 15.43 15.57 15.66 15.72 16.15 16.55 17.08 17.45 17.79 18.40 18.08 16.83 16.77

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:LP6 €2.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista